GRP
DFTX

Global Retirement Partners’s Definium Therapeutics DFTX Stock Holding History

Global Retirement Partners’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$7.58K Buy
566
+66
+13% +$817 ﹤0.01% 3269
2025
Q3 		$5.89K Buy
+500
New +$4.66K ﹤0.01% 2912

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Global Retirement Partners's DFTX Position: Q4 2025 in Review

Global Retirement Partners increased its Definium Therapeutics (DFTX) stake by 13% in Q4 2025, buying an estimated $817 and bringing the position to 566 shares worth $7.58K. The position accounts for ﹤0.01% of the portfolio, ranked #3269.

Global Retirement Partners first reported a position in DFTX in Q3 2025 and has held it in 2 quarters since. 208 funds tracked by Wall St. Rank hold DFTX as of Q4 2025.

  • Global Retirement Partners held 566 shares of Definium Therapeutics worth $7.58K as of Q4 2025.
  • Global Retirement Partners bought 66 Definium Therapeutics shares in Q4 2025, an estimated $817.
  • Definium Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3269 holding.
  • Global Retirement Partners first reported a position in Definium Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 208 funds tracked by Wall St. Rank held Definium Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.